Uknis Marc 4
4 · Gemini Therapeutics, Inc. /DE · Filed Apr 7, 2021
Insider Transaction Report
Form 4
Uknis Marc
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-05+277,117→ 277,117 totalExercise: $12.66Exp: 2031-02-04→ Common Stock (277,117 underlying)
Footnotes (1)
- [F1]This option shall vest and become exercisable over a period of four years from the Vesting Start Date, February 5, 2021 with 25% vesting on the one year anniversary of the Vesting Start Date, and the remainder vesting over a period of 36 months thereafter, provided that as of each such date the Grantee remains in a business relationship with the Company.